A New Mutation in FIG4 Causes a Severe Form of CMT4J Involving TRPV4 in the Pathogenic Cascade

Benoit J Gentil1, Erin O'Ferrall1, Colin Chalk1

  • 1Department of Neurology and Neurosurgery & Montreal Neurological Institute, McGill University, Quebec, Canada; and Department of Physiology & Biophysics and Howard Hughes Medical Institute, Department of Pharmacology, University of Washington, Seattle, Washington.

Insights

This study identifies a new FIG4 mutation causing severe Charcot-Marie-Tooth disease (CMT4J). FIG4 deficiency leads to cellular defects and interacts with TRPV4, offering potential therapeutic insights for this neuropathy.

Area of Science:

  • Genetics
  • Neuroscience
  • Cell Biology

Background:

  • Mutations in FIG4, a gene encoding a phosphoinositol(3,5) bisphosphate 5' phosphatase, are linked to recessive forms of Charcot-Marie-Tooth (CMT).
  • FIG4 plays a crucial role in vesicular trafficking and fusion, processes vital for cellular function.

Observation:

  • A novel intronic mutation in FIG4 was identified in a patient with severe CMT4J, characterized by demyelinating sensorimotor polyneuropathy.
  • Patient fibroblasts exhibited diminished FIG4 levels, indicating loss-of-function, and displayed cellular abnormalities including vacuolation and dispersed vesicular organelles.

Findings:

  • The patient was heterozygous for two FIG4 mutations: p.I41T and a novel intronic mutation (IVS17-10 T>G) predicted to cause splicing defects.
  • FIG4 deficiency resulted in the accumulation of the transient receptor cation channel, TRPV4, at the plasma membrane due to impaired protein turnover.
  • Knocking down FIG4 in motor neurons caused vacuolation and cell death, which was partially rescued by inhibiting TRPV4.

Implications:

  • This research elucidates a novel pathogenic FIG4 mutation and its severe clinical manifestation in CMT4J.
  • A functional interaction between FIG4 and TRPV4 is demonstrated, suggesting TRPV4 as a potential therapeutic target for FIG4-related neuropathies.
  • Understanding FIG4's role in vesicular trafficking and protein turnover provides insights into the mechanisms underlying CMT and other neurodegenerative disorders.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
932
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.5K
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
1.3K
Mutations01:39

Mutations

Overview
94.9K